ACIArchean Chemical Industries Limited
Chemicals · Chemicals · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for use as a water-soluble fertiliser in agricultural applications. Archean Chemical Industries Limited was founded in 2003 and is based in Chennai, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on ACI — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Overall evidence is weak (AlgoScore 25/100)
- • Revenue growth: -12.9% YoY
- • Profit growth: -73.1% YoY
- • RSI: 35
- • MACD: bearish
Bull case
- • Debt/Equity: 0.24
- • Promoter holding: 53.4%
- • Volume trend: 1.7x baseline
- • Volatility: 32% annualized
Bear case
- • Revenue growth: -12.9% YoY
- • Profit growth: -73.1% YoY
- • RSI: 35
- • MACD: bearish
Key risks
- • Weak fundamentals — technical strength may not sustain
- • Momentum is fading versus the broader market
- • Revenue growth: -12.9% YoY
- • Profit growth: -73.1% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹16.67). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.